GlaxoSmithKline Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
418 result(s) found, displaying 41 to 50
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for KOZENIS tafenoquine 50 mg film-coated dispersible tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JEMPERLI dostarlimab 500 mg concentrate for solution for infusion 10 mL vial.
-
Designation or determinationPriority review
-
Australian Public Assessment Report (AusPAR)New AusPAR for Jemperli (dostarlimab) for the treatment of mismatch repair deficient endometrial cancer.
-
Australian Public Assessment Report (AusPAR)AusPAR for Kozenis (tafenoquine) for prevention of relapse of Plasmodium vivax malaria in combination with chloroquine.
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd